| Primary |
| Pyrexia |
18.4% |
| Product Used For Unknown Indication |
11.0% |
| Drug Use For Unknown Indication |
9.8% |
| Sinusitis |
9.8% |
| Bronchitis |
8.6% |
| Urticaria |
6.7% |
| Rhinitis Allergic |
6.1% |
| Eczema |
5.5% |
| Dermatitis Atopic |
3.1% |
| Nasopharyngitis |
3.1% |
| Pruritus |
3.1% |
| Rhinitis |
2.5% |
| Dermatitis Allergic |
1.8% |
| Dermatitis Exfoliative |
1.8% |
| Erythema |
1.8% |
| Food Allergy |
1.8% |
| Arthropod Bite |
1.2% |
| Asthma |
1.2% |
| Atopy |
1.2% |
| House Dust Allergy |
1.2% |
|
| Malaise |
10.4% |
| Vertigo |
8.3% |
| Diabetes Mellitus |
6.3% |
| Respiratory Arrest |
6.3% |
| Urticaria |
6.3% |
| Agranulocytosis |
4.2% |
| Cerebral Haemorrhage |
4.2% |
| Convulsion |
4.2% |
| Exophthalmos |
4.2% |
| Hepatitis Acute |
4.2% |
| Jaundice |
4.2% |
| Liver Disorder |
4.2% |
| Loss Of Consciousness |
4.2% |
| Retinal Detachment |
4.2% |
| Retinal Haemorrhage |
4.2% |
| Rhabdomyolysis |
4.2% |
| Secondary Adrenocortical Insufficiency |
4.2% |
| Stevens-johnson Syndrome |
4.2% |
| Testicular Pain |
4.2% |
| Toxic Skin Eruption |
4.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
18.6% |
| Pruritus |
11.6% |
| Otitis Media Acute |
10.6% |
| Drug Eruption |
7.0% |
| Product Used For Unknown Indication |
6.0% |
| Bronchitis |
4.5% |
| Upper Respiratory Tract Inflammation |
4.5% |
| Erythema |
4.0% |
| Hepatic Neoplasm Malignant |
4.0% |
| Hypertension |
4.0% |
| Rhinitis Allergic |
4.0% |
| Hiv Infection |
3.5% |
| Gastric Ulcer |
3.0% |
| Prophylaxis |
2.5% |
| Gastritis |
2.0% |
| Infection Prophylaxis |
2.0% |
| Pyrexia |
2.0% |
| Renal Cell Carcinoma |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Toxic Skin Eruption |
2.0% |
|
| Toxic Skin Eruption |
16.1% |
| White Blood Cell Count Decreased |
9.7% |
| Cardio-respiratory Arrest |
6.5% |
| Drug Ineffective |
6.5% |
| Memory Impairment |
6.5% |
| Toxic Epidermal Necrolysis |
6.5% |
| Urticaria |
6.5% |
| Accidental Overdose |
3.2% |
| Activated Partial Thromboplastin Time Prolonged |
3.2% |
| Alanine Aminotransferase Increased |
3.2% |
| Aspartate Aminotransferase Increased |
3.2% |
| Asthenia |
3.2% |
| Bilirubin Conjugated Increased |
3.2% |
| Blood Fibrinogen Decreased |
3.2% |
| Convulsion |
3.2% |
| Decreased Appetite |
3.2% |
| Diarrhoea |
3.2% |
| Erythema Multiforme |
3.2% |
| Face Oedema |
3.2% |
| Faeces Pale |
3.2% |
|
| Concomitant |
| Prophylaxis |
22.3% |
| Hepatitis C |
8.9% |
| Product Used For Unknown Indication |
8.7% |
| Rectal Cancer |
7.9% |
| Pyrexia |
6.5% |
| Premedication |
6.3% |
| Hypertension |
5.5% |
| Rash |
4.3% |
| Drug Use For Unknown Indication |
3.5% |
| Asthma |
3.0% |
| Subclavian Vein Thrombosis |
2.6% |
| Renal Cell Carcinoma |
2.5% |
| Rhinitis Allergic |
2.5% |
| Bronchitis |
2.5% |
| Insomnia |
2.5% |
| Constipation |
2.2% |
| Behcet's Syndrome |
2.2% |
| Metastases To Bone |
2.0% |
| Upper Respiratory Tract Inflammation |
2.0% |
| Back Pain |
2.0% |
|
| Rash |
9.2% |
| Uveitis |
7.4% |
| Liver Disorder |
6.7% |
| Urticaria |
6.7% |
| Electrocardiogram Qt Prolonged |
5.5% |
| Hepatic Function Abnormal |
5.5% |
| Drug Eruption |
4.9% |
| Hepatitis Fulminant |
4.9% |
| Platelet Count Decreased |
4.9% |
| Pyrexia |
4.9% |
| Sepsis |
4.9% |
| Vomiting |
4.9% |
| Nausea |
4.3% |
| Renal Impairment |
4.3% |
| Tremor |
4.3% |
| Anxiety |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Anaemia |
3.1% |
| Haemolytic Anaemia |
3.1% |
| Myalgia |
3.1% |
|
